Logo

American Heart Association

  16
  0


Final ID: Wed147

Mechanisms Underlying the Effects of Empagliflozin on Osteogenic Differentiation in Aortic Valvular Interstitial Cells

Abstract Body:
Introduction:
Recent studies suggest that SGLT2 inhibitors may improve the prognosis of aortic stenosis (AS) by limiting calcification. Thickening and calcification of valve leaflets during AS is caused by osteoblastic transformation of valvular interstitial cells (VICs).
Aim:
This study aims to investigate whether empagliflozin (Empa) has a direct effect on osteoblastic transformation process of human VICs in vitro.
Methods:
hVICs were cultured in osteogenic medium (OM) and treated with or without Empa (30 nM or 150 nM) for 5 or 21 days. In a separate experiment, cells were cultured in OM under normal or high glucose (Glu) (25 mM) with or without Empa. Calcification was assessed by Alizarin Red staining. Expression of osteogenic markers (BMP2, RUNX2) and kinase signaling pathways was evaluated by Western blotting. Osteocalcin (OC), osteopontin (OP), and inflammatory mediators (IL-6, IL-1β) were quantified by ELISA.
Results:
Calcification was almost 6-fold higher in both OM and OM+Glu after 21 days compared with the control group (Alizarin concentration [Conc]: 0.13 vs 0.64 vs 0.65 mM, p<0.001). OC and OP levels increased significantly in both the OM and OM+glucose groups, accompanied by RUNX2 upregulation. At day 5, BMP2 expression increased 3.5-fold in both groups, along with a 5-fold increase in phospho/total ERK1/2. In contrast, phospho/total Akt and phospho/total p38 showed minor changes, and inflammatory mediators remained unchanged. Empa (30 or 150 nM) did not reduce calcification in VICs cultured in OM (Conc:1.30 and 0.95 vs 0.64 mM) or OM+glucose (Conc:0.79 and 0.80 vs 0.65 mM). Under normoglycaemic OM conditions, Empa even increased calcification after 21 days, and was associated with early activation of ERK1/2 and Akt without affecting BMP2 expression. In OM+glucose conditions, Empa did not affect either BMP2 expression or ERK1/2 activation.
Conclusion:
OM induced osteoblastic transformation of VICs via BMP2/ERK pathway, whereas high glucose had no direct effect. Empa did not inhibit calcification in isolated hVICs and, under normoglycaemic conditions, even worsened it, with early ERK and Akt activation. Further studies are needed to explore the effects of Empa on other elements of the calcification process.
  • Theodoropoulou, Theoni  ( First Cardiology Clinic, University of Athens, Hippokration Hospital , Athens , Greece )
  • Katsaouni, Athanasia - Paraskevi  ( Medicine School National and Kapodistrian University of Athens , Athens , Greece )
  • Mourouzis, Iordanis  ( Faculty of Medicine, National and Kapodistrian University of Athens , ATHENS , Greece )
  • Pantos, Constantinos  ( Faculty of Medicine, National and Kapodistrian University of Athens , ATHENS , Greece )
  • Tsioufis, Konstantinos  ( First Cardiology Clinic, University of Athens, Hippokration Hospital , Athens , Greece )
  • Toutouzas, Konstantinos  ( First Cardiology Clinic, University of Athens, Hippokration Hospital , Athens , Greece )
  • Author Disclosures:
Meeting Info:

Basic Cardiovascular Sciences 2026

2026

Boston, Massachusetts

Session Info:

Poster Session 3

Wednesday, 07/15/2026 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
Evaluation of Randomized Audit and Feedback to Increase Heart Failure Medication Optimization Among Primary Care Pharmacists in the Veterans Affairs Health Care System (PHARM-HF A&F Study)

Sandhu Alexander, Jurga Tomasz, Bosworth Hayden, Hess Paul, Heidenreich Paul, Steverson Alexandra, Sahay Anju, Gholami Parisa, Godbout Regina, Mambourg Scott, Marin Jennifer, Shah Kushal, Lin Shoutzu

Balloon-expandable versus Self-expandable transcatheter aortic valve replacement for failed surgical prostheses: A systematic review and meta-analysis

K. Awad Ahmed, Khalefa Basma, Negmeldin Aly Yassin Mazen, Arnaout Moumen, Mostafa Naydeen, S. Naeem Mariana, Eljadid Ghaith, Gardezi Syed Karam

More abstracts from these authors:
Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

You have to be authorized to contact abstract author. Please, Login
Not Available